With the hope of being able to aid the development of novel therapeutics, this study aimed at characterizing the EGF regulation in YB-1 and CXCL14 expression and their relevant kinase pathways in prostate cancer cells and tissues. This evidence concerns the gene EGF and prostate carcinoma.